Seleniso price after being included in medical insurance
Selinexor (Selinexor) original drug has been launched in China and is sold under the name of Selinexor tablets. Seliniso has been included in the medical insurance catalog through the relevant policies of the National Medical Insurance Bureau. This means that patients can purchase drugs through medical insurance when purchasing drugs in hospitals or pharmacies. Due to different reimbursement ratios in different regions, there may be slight differences in the price after reimbursement.
Selinexor is a cancer drug used to treat multiple myeloma. Its main ingredient is selinexor. After marketing approval, selinexor can also be used in combination with bortezomib and dexamethasone for adult patients who have received at least one previous treatment to increase its efficacy. Selinesol may also be used in combination with treatment in patients who have received at least four treatments and whose condition has worsened since the last treatment.
The reimbursement conditions for selinesol after entering Medicare include that it is limited to adult patients with relapsed or refractory multiple myeloma who have received previous treatment and are refractory to at least one proteasome inhibitor, one immunomodulator, and one anti-CD38 monoclonal antibody. According to relevant information, the price of each box of Seleniso sold in China and covered by medical insurance may be more than 20,000 yuan. Patients who meet the indications can use medical insurance for reimbursement, while patients who do not meet the conditions can only purchase the drugs at their own expense.
In general, the domestic launch and medical insurance coverage of Seleniso’s original drug is undoubtedly good news for domestic patients. Although prices are higher in overseas markets, the emergence of generic drugs has also provided patients with more affordable options. The price of generic drugs sold overseas may be more than 2,000 yuan, which is cheaper than the original drugs, and the ingredients of the two are basically the same. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)